Astellas Pharma (STU:YPH) Change In Inventory : €-381 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Astellas Pharma Change In Inventory?

Astellas Pharma's change in inventory for the quarter that ended in Mar. 2024 was €-95 Mil. It means Astellas Pharma's inventory increased by €95 Mil from Dec. 2023 to Mar. 2024 .

Astellas Pharma's change in inventory for the fiscal year that ended in Mar. 2024 was €-369 Mil. It means Astellas Pharma's inventory increased by €369 Mil from Mar. 2023 to Mar. 2024 .

Astellas Pharma's Total Inventories for the quarter that ended in Mar. 2024 was €1,527 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Astellas Pharma's Days Inventory for the quarter that ended in Mar. 2024 was 301.00.

Inventory Turnover measures how fast the company turns over its inventory within a year. Astellas Pharma's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.30.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Astellas Pharma's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.58.

Astellas Pharma Change In Inventory Historical Data

The historical data trend for Astellas Pharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Change In Inventory Chart

Astellas Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Inventory

Get a 7-Day Free Trial

-50.75

-17.91

184.22

-49.52

-368.67

Astellas Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-68.02	-109.41	-75.20	-101.84	-94.72

Astellas Pharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-381 Mil.

Astellas Pharma (STU:YPH) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Astellas Pharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1483.339	/	449.681	*	365 / 4
	=	301.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Astellas Pharma's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	449.681	/	1483.339
	=	0.30

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Astellas Pharma's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1483.339	/	2545.971
	=	0.58

Astellas Pharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (STU:YPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (STU:YPH) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

ALPMY:USA ALPMF:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.

Astellas Pharma (STU:YPH) Headlines

No Headlines